Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.
Pei S, Minhajuddin M, D'Alessandro A, Nemkov T, Stevens BM, Adane B, Khan N, Hagen FK, Yadav VK, De S, Ashton JM, Hansen KC, Gutman JA, Pollyea DA, Crooks PA, Smith C, Jordan CT.
Pei S, et al.
J Biol Chem. 2016 Nov 25;291(48):25280. doi: 10.1074/jbc.A116.750653.
J Biol Chem. 2016.
PMID: 27888238
Free PMC article.
No abstract available.